基因组变异对患者对吸入支气管扩展剂反应的影响:全面的更新
Maria Gabriella Matera1, Paola Rogliani2, Giuseppe Novelli3
1Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Naples, Italy.
Expert opinion on drug metabolism & toxicology
|June 3, 2023
概括
遗传变异影响支气管扩展剂反应 (BDR),特别是在β2-激动剂中. 进一步的药物遗传研究,整合多组和表观遗传数据,对于个性化支气管扩展剂治疗至关重要.
科学领域:
- 药物遗传学 药物遗传学
- 呼吸系统医学 呼吸系统医学
- 遗传学 是一个遗传学.
背景情况:
- 支气管扩展反应 (BDR) 受遗传因素的影响,许多单核酸多态 (SNP) 已被确定.
- 尽管进行了研究,但遗传变异尚未被纳入临床支气管扩展剂的使用中.
- 在BDR的个体变异性表明一个重要的遗传成分.
研究的目的:
- 审查遗传变异对支气管扩展剂反应的影响.
- 讨论支气管扩展器药物遗传学研究的现状和未来方向.
主要方法:
- 现有药物遗传学研究的叙述性审查.
- 专注于ADRB2和肌酸乙胆受体基因中的遗传变异.
- 分析SNP与BDR的关联,包括种族和年龄相关的个人资料.
主要成果:
- 在ADRB2基因 (A46G,C79G,C491T) 中的关键SNP显示为β2-激动剂反应的功能意义.
- 肌肉酸乙胆受体基因 (M2,M3) 的变异缺乏一致的药理相关性.
- 药物遗传发现的复制是有限的,BDR经常偏离SNP预测的反应.
结论:
- 对支气管扩展剂的药物遗传研究需要继续进行调查.
- 未来的研究必须纳入多组学和表观遗传数据,以全面了解BDR.
- 基于遗传特征的个性化支气管扩展剂治疗仍然是一个持续的挑战.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
319
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
319
COPD: Management Using Bronchodilators and Corticosteroids
256
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
256
Drugs Used in Lower Respiratory Disorders: Overview
509
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
509
Inhaled Medications
323
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
323
Asthma: Pathogenesis and Management
467
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
467
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
319
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
319


